Free Trial
NASDAQ:ADXN

Addex Therapeutics (ADXN) Stock Price, News & Analysis

Addex Therapeutics logo
$9.20 -0.29 (-3.01%)
As of 12:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Addex Therapeutics Stock (NASDAQ:ADXN)

Key Stats

Today's Range
$8.91
$9.44
50-Day Range
$7.75
$10.23
52-Week Range
$6.51
$13.27
Volume
4,839 shs
Average Volume
94,604 shs
Market Capitalization
$9.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.00
Consensus Rating
Buy

Company Overview

Addex Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

ADXN MarketRank™: 

Addex Therapeutics scored higher than 56% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Addex Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Addex Therapeutics has received no research coverage in the past 90 days.

  • Read more about Addex Therapeutics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Addex Therapeutics is -27.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Addex Therapeutics is -27.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Addex Therapeutics has a P/B Ratio of 0.89. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Addex Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    0.27% of the float of Addex Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Addex Therapeutics has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Addex Therapeutics has recently decreased by 4.35%, indicating that investor sentiment is improving.
  • Dividend Yield

    Addex Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Addex Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.27% of the float of Addex Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Addex Therapeutics has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Addex Therapeutics has recently decreased by 4.35%, indicating that investor sentiment is improving.
  • News Sentiment

    Addex Therapeutics has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Addex Therapeutics this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Addex Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.00% of the stock of Addex Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 16.14% of the stock of Addex Therapeutics is held by institutions.

  • Read more about Addex Therapeutics' insider trading history.
Receive ADXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ADXN Stock News Headlines

Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
See More Headlines

ADXN Stock Analysis - Frequently Asked Questions

Addex Therapeutics' stock was trading at $7.00 at the start of the year. Since then, ADXN stock has increased by 31.4% and is now trading at $9.1950.

Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) issued its quarterly earnings results on Friday, November, 22nd. The company reported ($2.77) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.40) by $1.37. Addex Therapeutics had a net margin of 3,584.49% and a negative trailing twelve-month return on equity of 54.27%.
Read the conference call transcript
.

Shares of Addex Therapeutics reverse split before market open on Monday, October 23rd 2023.The 1-20 reverse split was announced on Monday, October 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of ADXN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Addex Therapeutics investors own include Arista Networks (ANET), Adobe (ADBE), NVIDIA (NVDA), Broadcom (AVGO), GE Aerospace (GE), Vista Energy (VIST) and Arch Capital Group (ACGL).

Company Calendar

Last Earnings
11/22/2024
Today
7/09/2025
Next Earnings (Estimated)
9/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ADXN
CIK
1574232
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$30.00
Potential Upside/Downside
+226.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$8.02 million
Net Margins
3,584.49%
Pretax Margin
-2,307.03%

Debt

Sales & Book Value

Annual Sales
$460 thousand
Price / Cash Flow
N/A
Book Value
$10.37 per share
Price / Book
0.89

Miscellaneous

Free Float
901,000
Market Cap
$9.75 million
Optionable
Not Optionable
Beta
1.65
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ADXN) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners